Literature DB >> 21773759

Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension.

Paolo Calabrò1, Giuseppe Limongelli, Valeria Maddaloni, Carmine Dario Vizza, Michele D'Alto, Raffaella D'Alessandro, Roberto Poscia, Paola Argiento, Brunella Ziello, Roberto Badagliacca, Emanuele Romeo, Giuseppe Pacileo, Maria Giovanna Russo, Francesco Fedele, Raffaele Calabrò.   

Abstract

This study analyses the frequency and the potential role of two polymorphisms, the +134del/insA, located in the gene encoding for Endothelin-1 (EDN1), and the His323His in the gene encoding for Endothelin receptor type A (EDNRA) in a cohort of 98 consecutive patients with pulmonary arterial hypertension from two different Cardiology Units (Mid-South of Italy), and in 100 healthy Caucasian subjects randomly recruited from the same area. Cardiac anatomy and function were analysed by non invasive diagnostic imaging techniques (Echocardiography standard m-mode, 2D, colour-Doppler) and by invasive studies (cardiac catheterization). Molecular screening of the region of interest was performed by automated sequencing. At univariate analysis, patients with the His323His TT genotype show a lower cardiac index (2 ± 0.6 vs. 2.3 ± 0.6; p = 0.05) and a higher indexed pulmonary vascular resistance (18.8 ± 9.6 vs. 14.2 ± 6.9; p = 0.01) at cardiac catheterization. A logistic multivariate model shows idiopathic disease (p = 0.01; OR = 3.8; CI = 1.3-11) and indexed pulmonary vascular resistances (p = 0.01; OR = 1.1; CI = 1-1.2) as independent predictors of TT genotype. Our findings may suggest a potential link between specific genotypes in the EDNRA gene and susceptibility for PAH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21773759     DOI: 10.1007/s11739-011-0643-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  20 in total

1.  Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor.

Authors:  K Hosoda; K Nakao; N Tamura; H Arai; Y Ogawa; S Suga; S Nakanishi; H Imura
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

2.  Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension.

Authors:  C Rubens; R Ewert; M Halank; R Wensel; H D Orzechowski; H P Schultheiss; G Hoeffken
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

3.  Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension.

Authors:  E L Schiffrin; L Y Deng; P Sventek; R Day
Journal:  J Hypertens       Date:  1997-01       Impact factor: 4.844

4.  The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people.

Authors:  L Tiret; O Poirier; V Hallet; T A McDonagh; C Morrison; J J McMurray; H J Dargie; D Arveiler; J B Ruidavets; G Luc; A Evans; F Cambien
Journal:  Hypertension       Date:  1999-05       Impact factor: 10.190

5.  Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.

Authors:  Ryutaro Yamanaka; Fumio Otsuka; Kazufumi Nakamura; Misuzu Yamashita; Hiroyuki Otani; Masaya Takeda; Yoshinori Matsumoto; Kengo F Kusano; Hiroshi Ito; Hirofumi Makino
Journal:  Hypertens Res       Date:  2010-02-26       Impact factor: 3.872

6.  Endothelin-1 gene and progression of blood pressure and left ventricular mass: longitudinal findings in youth.

Authors:  Yanbin Dong; Xiaoling Wang; Haidong Zhu; Frank A Treiber; Harold Snieder
Journal:  Hypertension       Date:  2004-10-25       Impact factor: 10.190

7.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Functional significance of a hereditary adenine insertion variant in the 5'-UTR of the endothelin-1 gene.

Authors:  Katrin Popowski; Bernhard Sperker; Heyo K Kroemer; Ulrich John; Michael Laule; Karl Stangl; Ingolf Cascorbi
Journal:  Pharmacogenetics       Date:  2003-08

10.  In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats.

Authors:  R Day; R Larivière; E L Schiffrin
Journal:  Am J Hypertens       Date:  1995-03       Impact factor: 2.689

View more
  12 in total

1.  Pulmonary hypertension: have we learned enough yet?

Authors:  Davide Cattano; Marie Francoise Doursout
Journal:  Intern Emerg Med       Date:  2012-08-18       Impact factor: 3.397

2.  Elevated blood pressure: Our family's fault? The genetics of essential hypertension.

Authors:  Aniket Natekar; Randi L Olds; Meghann W Lau; Kathleen Min; Karra Imoto; Thomas P Slavin
Journal:  World J Cardiol       Date:  2014-05-26

3.  Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.

Authors:  Angela Ghatnekar; Izabela Chrobak; Charlie Reese; Lukasz Stawski; Francesca Seta; Elaine Wirrig; Jesus Paez-Cortez; Margaret Markiewicz; Yoshihide Asano; Russell Harley; Richard Silver; Carol Feghali-Bostwick; Maria Trojanowska
Journal:  Am J Pathol       Date:  2013-04-11       Impact factor: 4.307

4.  Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening.

Authors:  Luise Holzhauser; Ronald Zolty
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 5.  Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics.

Authors:  Julio D Duarte; Rebekah L Hanson; Roberto F Machado
Journal:  Future Cardiol       Date:  2013-05

Review 6.  Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.

Authors:  Arunabh Talwar; Joe G N Garcia; Halley Tsai; Matthew Moreno; Tim Lahm; Roham T Zamanian; Roberto Machado; Steven M Kawut; Mona Selej; Stephen Mathai; Laura Hoyt D'Anna; Sonu Sahni; Erik J Rodriquez; Richard Channick; Karen Fagan; Michael Gray; Jessica Armstrong; Josanna Rodriguez Lopez; Vinicio de Jesus Perez
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

7.  The association of endothelin-1 gene polymorphism and its plasma levels with hypertension and coronary atherosclerosis.

Authors:  Nazanin Ebrahimi; Gholamreza Asadikaram; Abbas Mohammadi; Yunes Jahani; Mina Moridi; Mohammad Masoumi
Journal:  Arch Med Sci       Date:  2019-07-22       Impact factor: 3.318

8.  Pulmonary hypertension in left heart disease.

Authors:  Pratishtha Mehra; Vimal Mehta; Rishi Sukhija; Anjan K Sinha; Mohit Gupta; M P Girish; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-17       Impact factor: 3.318

Review 9.  Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease.

Authors:  Hassaan B Arshad; Valeria E Duarte
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-07-01

Review 10.  A systematic review of genetic mutations in pulmonary arterial hypertension.

Authors:  Gerardo Garcia-Rivas; Carlos Jerjes-Sánchez; David Rodriguez; José Garcia-Pelaez; Victor Trevino
Journal:  BMC Med Genet       Date:  2017-08-02       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.